Resveratrol regulates insulin-like growth factor-II in breast cancer cells

Sharda Vyas1, Yayesh Asmerom, Daisy D De León

  • 1Department of Anatomy, CSP 11012, Loma Linda University, Loma Linda, California 92350, USA.

Endocrinology
|July 23, 2005
PubMed

Insights

Resveratrol (RSV) affects Insulin-like Growth Factor-II (IGF-II) in breast cancer cells. This study shows IGF-II mediates RSV

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cancer Research

Background:

  • Insulin-like Growth Factor-II (IGF-II) is a key regulator in breast cancer, influencing cell proliferation and apoptosis.
  • Resveratrol (RSV), a phytoestrogen, exhibits anti-cancer properties and interacts with estrogen pathways.
  • Estrogen's role in regulating IGF-II suggests a potential link between RSV and IGF-II in breast cancer.

Purpose of the Study:

  • To investigate if RSV modulates IGF-II expression and secretion in breast cancer cells.
  • To determine if RSV's effect on IGF-II is dependent on estrogen receptor (ER) status.
  • To ascertain whether IGF-II mediates the effects of RSV on breast cancer cell growth and survival.

Main Methods:

  • Treatment of ER-positive (MCF-7, T47D) and ER-negative (MCF-10) breast cancer cells with varying concentrations of RSV.
  • Analysis of precursor IGF-II mRNA and protein levels.
  • Assessment of cell growth inhibition and survival using IGF-I receptor blocking antibodies and tamoxifen.
  • Evaluation of IGF-I levels.

Main Results:

  • Low-dose RSV (10^-6 M) stimulated IGF-II in ER-positive cells, an effect blocked by 17beta-estradiol.
  • RSV-stimulated growth was inhibited by an IGF-I receptor antibody or tamoxifen.
  • High-dose RSV (10^-4 M) inhibited IGF-II secretion and cell growth in ER-positive cells.
  • RSV inhibited cell growth in ER-negative cells, but IGF-II levels did not increase.

Conclusions:

  • Resveratrol differentially regulates IGF-II in breast cancer cells, with effects dependent on concentration and ER status.
  • IGF-II plays a mediating role in both the growth-promoting and growth-inhibitory effects of RSV on breast cancer cells.
  • These findings highlight a complex interaction between RSV, IGF-II, and ER signaling in breast cancer therapy and chemoprevention.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...